Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 28, 2024

Semaglutide and Diuretic Use in Obesity-Related HFpEF

European Heart Journal


Additional Info

European Heart Journal
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials
Eur Heart J 2024 May 13;[EPub Ahead of Print], SJ Shah, K Sharma, BA Borlaug, J Butler, M Davies, DW Kitzman, MC Petrie, S Verma, S Patel, KM Chinnakondepalli, MN Einfeldt, TJ Jensen, S Rasmussen, R Asleh, T Ben-Gal, MN Kosiborod

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading